About the Pre-Conference Planner
- Our analyst team have screened the abstracts due to be presented and have identified 85 abstracts (77 clinical and 8 preclinical) associated with trial or drug records on Beacon DDR.
- ASCO abstracts have been screened for relevancy by title only, full abstracts will be screened for relevancy when available from May 26th. Additional relevant data will be included in the post-conference report.
- Data from ASCO 2022 will populated on Beacon over the coming weeks. Remember, you can keep a track of specific drug and trial records of interest by adding the page to your personal watch list, following which you will be notified of any updates on Beacon.
Find out more
This insight and data is part of the subscription to Beacon DDR.
Speak with our Team
Our dedicated Sales and Research teams can help you with questions by showing you how this insight and data is collated on Beacon
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements